Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Bryan Walker
Infectious complications among CD19 CAR‐T cell therapy recipients: A single‐center experience
ANC absolute neutrophil count BSI bloodstream infection CAR chimeric antigen receptor CI cumulative incidence CMV cytomegalovirus CRS cytokine release syndrome HSCT hematopoietic stem cell transplant HSV herpes simplex virus HT CAR-HEMATOTOX ICANS immune effector cell-associated neurotoxicity syndrome IgG immunoglobulin G IVIG intravenous immunoglobulin G PJP Pneumocystis jirovecii pneumonia VZV varicella zoster virus 1 INTRODUCTION CD19 chimeric antigen receptor (CAR)-T cell therapy is an...
Anatomy of arbitration agreements
Introduction Scope Seat Governing law Arbitrators Comment Introduction Arbitration is an inherently flexible mechanism intended to streamline the dispute resolution process to meet the parties' specific needs.
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary | Neurodegenerative Disease Management
Neurodegenerative Disease ManagementVol. 12, No. 1 Plain Language Summary of PublicationOpen Access , , , , , , , & Abstract People with multiple sclerosis (also shortened to MS) may have difficulties staying on treatment due to side effects. Cladribine tablets, approved for treating relapsing forms of MS, are given by mouth for four short periods over two years. The benefit of convenient dosing may be lost if side effects prevent people with MS from finishing their treatment.
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary | Neurodegenerative Disease Management
Neurodegenerative Disease ManagementVol. 12, No. 1 Plain Language Summary of PublicationOpen Access Abstract People with multiple sclerosis (also shortened to MS) may have difficulties staying on treatment due to side effects. Cladribine tablets, approved for treating relapsing forms of MS, are given by mouth for four short periods over two years. The benefit of convenient dosing may be lost if side effects prevent people with MS from finishing their treatment.
Recent Judicial Decisions of Interest to Energy Lawyers
Bryan Walker Lucy L'Hirondelle Abstract This article summarizes a number of recent judicial decisions of interest to energy lawyers. The authors review and comment on the past year’s case law in several areas including alternative dispute resolution, bankruptcy and insolvency, contractual interpretation (including operator agreements), competition law, corporate separateness, damages and limitations of liability, Indigenous law, torts, and selected developments relating to summary dismissal.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Bryan
Contact Bryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack